Lumen Raises $62M for Handheld Device to Measure Metabolic Health

Lumen Raises $62M to Empower People to Optimize Metabolic Health Lumen Raises $62M to Empower People to Optimize Metabolic Health

What You Should Know:

Lumen, the metabolic health company behind the first handheld device to measure your metabolism through the breath, today announced that it has raised $62M in a series B funding round led by Pitango Venture Capital.

– Participating investors include Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital, and Disruptive VC.

World’s Largest Platform For Measuring Metabolism To Expand Business Growth and Research

Lumen helps people achieve metabolic health by making better nutrition and lifestyle choices so they can enjoy a higher quality of life and live longer. It is a service that includes an app and a device that reveals the state of the user’s metabolism and shows them the impact of one’s nutrition and lifestyle on their body.

With the metabolic health crisis contributing to over $464B in annual US healthcare costs and affecting 8 out of 10 adults in the U.S., the investment will enable the company to:

1. Reach more communities in the US and globally

2. Expand its personalized nutrition and lifestyle guidance solution for consumers

3. Continue to support research partnerships with academic institutions

“Understanding the impact of nutrition, exercise, sleep, and stress on your metabolism is key to reaching your health goals. One of the things we’re most excited about is enabling people to take care of the “engine of the body”, which is our metabolism,” said Daniel Tal, CEO and Co-Founder of Lumen. “Over the last year, Lumen customers discovered what types of foods they should be eating and what habits they should change or maintain. It’s been incredible to see the impact Lumen has had on so many people in such a short period of time.”

The number of people using Lumen to improve their metabolic health has grown exponentially since the product’s launch. Today more than 2 million monthly metabolic measurements are conducted at home or on the go with the Lumen handheld device. Traditionally, this process was only available in hospitals and clinics via a 45-minute expensive lab test.

Lumen connects with health data platforms including Apple Healthkit, Google Fit and Garmin. It uses robust data sets in machine learning to provide daily personalized nutrition guidance to each person based on their lifestyle and metabolic profile. To further scale this area, six months ago, the company appointed a new CTO, Eliran Fallah, a former tech executive at Microsoft, Google and Waze with vast experience in the field.

Since inception, Lumen has been committed to investing in clinical research related to its community’s most pressing health problems. Over the past year, the company has conducted research studies in several health fields with top academic institutions, including Purdue University’s Whistler Center for Carbohydrate Research, University of Toronto’s Faculty of Kinesiology and Physical Education and ARU Cambridge.

In October 2022, a study done in collaboration with the endocrinology department at the Tel Aviv Sourasky Medical Center was published in the Obesity Facts journal. The study’s findings revealed how metabolism-based nutrition can reverse prediabetes conditions. Over 12 weeks prediabetic participants measured their metabolism using the Lumen device and followed its nutrition and lifestyle guidance which resulted in lower Hb1c levels, an average weight loss of 13 lbs. and 3% body fat reduction.

“Until now, studying metabolism with the standard equipment was challenging for both researchers and participants. The data collection was minimal and would require participants to come to a clinic for each measurement and a practitioner to analyze the results. Now researchers can easily collect multiple data points from participants and build more complex research protocols that unveil new physiological findings,” said Dr. Merav Mor Ph.D, Chief Scientist and Co-Founder at Lumen.